Jiangsu Nhwa Pharmaceutical Co., LTD (002262-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Jiangsu Nhwa Pharmaceutical Co., LTD maintains a healthy position.
The total current assets of the company are valued at $5254561353.
This represents a growth rate of 12.992% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $2158946445, exhibiting a growth rate of 40.904% year-on-year.
The receivables, another significant portion of the current assets, are valued at $1091688107.
The year-on-year growth rate for receivables is 16.476%.
The inventory, which forms a critical part of the assets, is valued at $628637457.
This represents a healthy year-on-year growth of -12.243%
On the liabilities side, the company's current liabilities total $814027830.
This reflects a growth rate of 2.530% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
2158.95
1532.21
1607.59
1402.42
1820.81
971.85
Receavebles
1091.69
937.26
757.72
640.59
675.06
1022.48
Inventory
628.64
716.34
604.33
433.86
345.48
410.49
Other
40.29
12.59
15.14
5.71
92.09
506.66
Total Current Assets
5254.56
4650.40
4043.18
3319.58
3003.45
2911.49
Acc Payable
216.28
255.74
267.17
165.19
127.55
352.77
Short Term Debt
136.77
50.63
63.01
38.00
38.00
317.33
Other Current Liab
434.49
426.78
2.23
4.26
31.87
218.99
Current Liabilities
814.03
793.94
681.96
574.95
515.92
983.62
Capital Structure
When examining the capital structure of Jiangsu Nhwa Pharmaceutical Co., LTD, it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $7603954816.
When juxtaposed with the previous year, this marks a growth rate of 11.572%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $929208374.
Compared to the prior year, this reflects a growth rate of -7.573%.
The long-term debt forms a sizable part of these liabilities, coming in at $230000.
Over the last year, the long-term debt has grown by -99.438%.
On the asset side, the cash and equivalent reserves are worth $1635420861.
The year-on-year growth of these reserves is 7.622%.
The company's common stock, another important asset, holds a value of $1007588092, growing at a rate of 0.000% from the previous year.
Finally, the company's retained earnings stand at $5078301392, marking a growth rate of 20.746% year-over-year.
These earnings represent the profits that Jiangsu Nhwa Pharmaceutical Co., LTD has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$7,603.95
Total liabilities
$929,208,374.00
Long term debt
$0.23
Cash and eqv
$1,635,420,861.00
Goodwill
$0.00
Retained earnings
$5,078,301,392.00
Common stock
$90.00
Enterprise Value
$21.91
Historical dividend key summary
Jiangsu Nhwa Pharmaceutical Co., LTD's dividend per share is $0.2, showing the earnings shared with shareholders per share. It has grown by 0.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2023
0.000
0.200
0.000
0.000
0.200
2022
0.000
0.200
0.000
0.000
0.200
2021
0.000
0.100
0.000
0.000
0.100
2020
0.000
0.100
0.000
0.000
0.100
2019
0.000
0.060
0.000
0.000
0.060
2018
0.000
0.050
0.000
0.000
0.050
2017
0.000
0.037
0.000
0.000
0.037
2016
0.000
0.029
0.000
0.000
0.029
2015
0.000
0.024
0.000
0.000
0.024
2014
0.000
0.018
0.000
0.000
0.018
2013
0.000
0.021
0.000
0.000
0.021
2012
0.000
0.013
0.000
0.000
0.013
2011
0.000
0.013
0.000
0.000
0.013
2010
0.000
0.010
0.000
0.000
0.010
2009
0.000
0.014
0.000
0.000
0.014
Net earnings per share (EPS)
Jiangsu Nhwa Pharmaceutical Co., LTD has an EPS of $0.26, which signifies the profit allocated per share of common stock. With a growth rate of -74.757% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2024
0.26
-
-
-
0.26
2023
0.23
0.31
0.34
0.15
1.03
2022
0.19
0.26
0.3
0.16
0.91
2021
0.17
0.25
0.27
0.13
0.82
2020
0.14
0.22
0.21
0.15
0.72
2019
0.12
0.19
0.2
0.14
0.65
2018
0.1
0.16
0.16
0.1
0.52
2017
0.0845
0.12
0.13
0.0496
0.38
2016
0.0684
0.1
0.0815
0.0551
0.31
2015
0.0595
0.1
0.0689
0.0421
0.27
2014
0.0485
0.0773
0.0581
0.0423
0.23
2013
0.0389
0.0692
0.0472
0.0311
0.19
2012
0.0338
0.0539
0.0398
0.0268
0.15
2011
0.025
0.0405
0.034
0.021
0.11
2010
0.0189
0.0296
0.0257
0.0133
0.09
2009
0.0129
0.02
0.017
0.0112
0.06
2008
0.0123
0.0188
0.0144
0.0127
0.05
2007
-
-
0.0151
0.0099
0.03
Brief information
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) stock split history
Understanding the historical stock splits of Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on May 12, 2017 with a ratio of 16:10. Throughout its history, the company has undergone 7 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
